BGLAP and type 1 diabetes mellitus: Osteoblast‐derived BTMs such as OCN and alkaline phosphatase (ALP) have received the greatest amount of focus in understanding reductions in bone quality with diabetes, in part because of the bone–pancreas feedback loop.(20) However, because osteocytes are the master regulators of bone remodeling, osteocyte‐derived proteins are more often recognized as potential mediators of reduced bone quality with T1D.